Trademark Attorney / Law Firm

Banafsheh Akhlaghi – Trademark Portfolio

Banafsheh Akhlaghi specializes in Class 41 (Education & Entertainment) trademark filings before the United States Patent and Trademark Office (USPTO), with 3 of 4 total filings concentrated in this category. The practice also covers Class 44 (Medical Services) along with 2 other Nice Classification classes. Filing activity spans from 2019 to 2021. Currently, 1 trademark is registered.

4 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Banafsheh Akhlaghi's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

41
Education & Entertainment (3 filings)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademark applications has Banafsheh Akhlaghi filed?

Banafsheh Akhlaghi has filed 4 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 3 abandoned.

What trademark classes does Banafsheh Akhlaghi specialize in?

Banafsheh Akhlaghi has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

How long has Banafsheh Akhlaghi been filing trademarks?

Banafsheh Akhlaghi's trademark filing history with the USPTO spans from 2019 to 2021, covering 2 years of trademark practice. During this period, Banafsheh Akhlaghi has handled 4 trademark applications.

What is Banafsheh Akhlaghi's trademark registration success rate?

Banafsheh Akhlaghi has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.